These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19487150)

  • 1. Increased serum ferritin levels in patients with Crimean-Congo hemorrhagic fever: can it be a new severity criterion?
    Barut S; Dincer F; Sahin I; Ozyurt H; Akkus M; Erkorkmaz U
    Int J Infect Dis; 2010 Jan; 14(1):e50-4. PubMed ID: 19487150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
    Ozturk B; Kuscu F; Tutuncu E; Sencan I; Gurbuz Y; Tuzun H
    J Clin Virol; 2010 Feb; 47(2):115-9. PubMed ID: 20005156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.
    Yilmaz G; Koksal I; Topbas M; Yilmaz H; Aksoy F
    J Clin Virol; 2010 Apr; 47(4):361-5. PubMed ID: 20149724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine levels in Crimean-Congo hemorrhagic fever.
    Papa A; Bino S; Velo E; Harxhi A; Kota M; Antoniadis A
    J Clin Virol; 2006 Aug; 36(4):272-6. PubMed ID: 16765637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
    Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
    Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
    Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
    Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.
    Cevik MA; Erbay A; Bodur H; Gülderen E; Baştuğ A; Kubar A; Akinci E
    Int J Infect Dis; 2008 Jul; 12(4):374-9. PubMed ID: 18063402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-type natriuretic peptide is associated with the severity of Crimean-Congo hemorrhagic fever.
    Turkdogan KA; Zorlu A; Engin A; Guven FM; Polat MM; Turgut OO; Yilmaz MB
    Int J Infect Dis; 2012 Aug; 16(8):e616-20. PubMed ID: 22695238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.
    Ekiz F; Gürbüz Y; Basar Ö; Aytekin G; Ekiz Ö; Sentürk ÇŞ; Aktas B; Yılmaz B; Altınbaş A; Çoban Ş; Şencan İ
    Clin Appl Thromb Hemost; 2013; 19(4):441-4. PubMed ID: 22431857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.
    Ertugrul B; Uyar Y; Yavas K; Turan C; Oncu S; Saylak O; Carhan A; Ozturk B; Erol N; Sakarya S
    Int J Infect Dis; 2009 Nov; 13(6):e431-6. PubMed ID: 19409826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
    Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
    Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum nitric oxide levels in patients with Crimean-Congo haemorrhagic fever.
    Tütüncü EE; Gurbuz Y; Ozturk B; Kuscu F; Sencan I
    Scand J Infect Dis; 2010 May; 42(5):385-8. PubMed ID: 20095935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic and prognostic significance of SCUBE1 levels in Crimean-Congo hemorrhagic fever.
    Menteşe A; Yilmaz G; Sümer A; Arslan M; Karahan SC; Köksal I
    Int J Infect Dis; 2013 Nov; 17(11):e1042-5. PubMed ID: 23632301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever.
    Bodur H; Akinci E; Ongürü P; Uyar Y; Baştürk B; Gözel MG; Kayaaslan BU
    Int J Infect Dis; 2010 Aug; 14(8):e704-7. PubMed ID: 20627646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
    Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
    J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever.
    Sonmez M; Aydin K; Durmus A; Sucu N; Yilmaz M; Akdogan E; Koksal I; Ovali E; Omay SB
    J Infect; 2007 Aug; 55(2):184-7. PubMed ID: 17418898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the relationship between serum levels of VEGF and sVEGFR1 with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.
    Bakir M; Bakir S; Sari I; Celik VK; Gozel MG; Engin A
    J Med Virol; 2013 Oct; 85(10):1794-801. PubMed ID: 23868816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever.
    Tasdelen Fisgin N; Tanyel E; Doganci L; Tulek N
    Trop Doct; 2009 Jul; 39(3):158-60. PubMed ID: 19535753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.
    Dokuzoguz B; Celikbas AK; Gök ŞE; Baykam N; Eroglu MN; Ergönül Ö
    Clin Infect Dis; 2013 Nov; 57(9):1270-4. PubMed ID: 23946218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever.
    Bakir M; Engin A; Gozel MG; Elaldi N; Kilickap S; Cinar Z
    J Vector Borne Dis; 2012 Jun; 49(2):105-10. PubMed ID: 22898483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.